Recombinant Human Otoraplin protein is a Human Full Length protein, in the 17 to 128 aa range, expressed in Escherichia coli, with >95% purity and suitable for SDS-PAGE.
M V H G I F M D R L A S K K L C A D D E C V Y T I S L A S A Q E D Y N A P D C R F I N V K K G Q Q I Y V Y S K L V K E N G A G E F W A G S V Y G D G Q D E M G V V G Y F P R N L V K E Q R V Y Q E A T K E V P T T D I D F F C E
| Application | Reactivity | Dilution info | Notes |
|---|---|---|---|
Application SDS-PAGE | Reactivity Reacts | Dilution info - | Notes - |
FDP, MIAL, UNQ3054/PRO9873, OTOR, Otoraplin, Fibrocyte-derived protein, Melanoma inhibitory activity-like protein
Recombinant Human Otoraplin protein is a Human Full Length protein, in the 17 to 128 aa range, expressed in Escherichia coli, with >95% purity and suitable for SDS-PAGE.
ab50079 purity was determined also by HPLC.Endotoxin level is less than 0.1 ng per µg (1EU/µg).
Belongs to the MIA/OTOR family.
Otoraplin also known as Otoraplin A is a protein with a molecular mass of approximately 14 kDa. It belongs to the fibroblast growth factor (FGF) family and is mainly expressed in the ear especially in the cochlear and vestibular tissues. Otoraplin acts mechanically through its involvement in cellular signaling processes. Although studied less extensively its presence in neural tissues indicates that it might contribute to the developing auditory and equilibrium systems.
This protein assists in cell proliferation survival and differentiation within ear tissues. The precise role is not fully determined yet but its membership in the protein family suggests that it might interact with others in similar contexts. Otoraplin does not seem part of a large complex but likely still has interactions as part of signaling networks important to tissue maintenance and function.
Otoraplin appears implicated in the fibroblast growth factor signaling pathway. This pathway is essential for various cellular processes including development and wound healing. In this pathway proteins like FGFR1 (Fibroblast Growth Factor Receptor 1) interact closely with Otoraplin indicating a potential collaborative role in signal cascade events which lead to desired cellular outcomes.
Research so far associates Otoraplin with otosclerosis a condition affecting bone growth in the ear and hearing loss. Abnormal regulation or expression of Otoraplin might disrupt normal ear tissue processes potentially causing these conditions. The involvement of FGFR1 in similar disorders further suggests that Otoraplin might play a relevant role in the pathological development associated with these auditory impairments.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com